TES | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	30 studies	29% ± 8%	Explore
non-classical monocyte	16 studies	30% ± 12%	Explore
CD4-positive, alpha-beta T cell	15 studies	21% ± 7%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	34% ± 11%	Explore
classical monocyte	14 studies	25% ± 9%	Explore
CD16-negative, CD56-bright natural killer cell, human	14 studies	29% ± 9%	Explore
CD8-positive, alpha-beta T cell	13 studies	24% ± 7%	Explore
mature NK T cell	13 studies	29% ± 9%	Explore
type I pneumocyte	12 studies	38% ± 11%	Explore
B cell	12 studies	20% ± 3%	Explore
endothelial cell	11 studies	27% ± 13%	Explore
epithelial cell	11 studies	32% ± 21%	Explore
dendritic cell	10 studies	29% ± 15%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	10 studies	22% ± 5%	Explore
conventional dendritic cell	10 studies	29% ± 11%	Explore
regulatory T cell	10 studies	22% ± 7%	Explore
basal cell	10 studies	29% ± 9%	Explore
gamma-delta T cell	10 studies	28% ± 9%	Explore
T cell	9 studies	19% ± 3%	Explore
monocyte	9 studies	20% ± 4%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	9 studies	22% ± 5%	Explore
memory B cell	9 studies	20% ± 4%	Explore
mucosal invariant T cell	8 studies	24% ± 5%	Explore
CD8-positive, alpha-beta memory T cell	8 studies	22% ± 8%	Explore
naive B cell	7 studies	20% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell	7 studies	23% ± 4%	Explore
smooth muscle cell	7 studies	30% ± 14%	Explore
endothelial cell of artery	6 studies	20% ± 5%	Explore
pericyte	6 studies	21% ± 4%	Explore
ciliated cell	6 studies	34% ± 19%	Explore
secretory cell	6 studies	22% ± 6%	Explore
macrophage	6 studies	19% ± 2%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	20% ± 6%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	27% ± 5%	Explore
innate lymphoid cell	5 studies	28% ± 8%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	19% ± 4%	Explore
goblet cell	5 studies	32% ± 19%	Explore
mononuclear phagocyte	4 studies	22% ± 3%	Explore
myofibroblast cell	4 studies	23% ± 6%	Explore
lymphocyte	4 studies	24% ± 10%	Explore
vein endothelial cell	4 studies	23% ± 7%	Explore
squamous epithelial cell	3 studies	38% ± 26%	Explore
leukocyte	3 studies	25% ± 9%	Explore
exhausted T cell	3 studies	23% ± 5%	Explore
hematopoietic precursor cell	3 studies	27% ± 10%	Explore
brush cell	3 studies	27% ± 9%	Explore
club cell	3 studies	31% ± 8%	Explore
pancreatic ductal cell	3 studies	53% ± 21%	Explore
group 3 innate lymphoid cell	3 studies	26% ± 9%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	3 studies	27% ± 7%	Explore
double negative thymocyte	3 studies	31% ± 6%	Explore
myoepithelial cell	3 studies	37% ± 6%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	13 studies	24% ± 7%	Explore
lung	4 studies	27% ± 6%	Explore
intestine	4 studies	18% ± 2%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	8204.13	1444 / 1445	100%	66.78	183 / 183
intestine	100%	12019.74	966 / 966	99%	81.10	524 / 527
stomach	100%	5738.01	358 / 359	100%	74.77	285 / 286
thymus	100%	4099.14	651 / 653	100%	86.90	602 / 605
bladder	100%	9524.67	21 / 21	99%	78.09	499 / 504
lung	98%	3728.67	566 / 578	100%	83.32	1154 / 1155
uterus	98%	9916.90	167 / 170	98%	89.34	452 / 459
prostate	96%	5117.68	235 / 245	99%	54.52	496 / 502
breast	98%	3235.28	448 / 459	97%	63.16	1084 / 1118
skin	97%	2503.73	1748 / 1809	85%	47.19	403 / 472
pancreas	80%	1427.15	261 / 328	98%	74.16	174 / 178
kidney	78%	1640.26	69 / 89	99%	78.11	893 / 901
ovary	22%	598.14	39 / 180	99%	58.66	424 / 430
ureter	0%	0	0 / 0	100%	27.42	1 / 1
blood vessel	99%	9931.92	1319 / 1335	0%	0	0 / 0
spleen	99%	3111.78	238 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	98%	52.95	44 / 45
adipose	96%	2370.83	1158 / 1204	0%	0	0 / 0
peripheral blood	93%	3499.26	867 / 929	0%	0	0 / 0
lymph node	0%	0	0 / 0	93%	38.90	27 / 29
liver	14%	249.52	32 / 226	49%	17.07	200 / 406
adrenal gland	17%	224.45	44 / 258	22%	5.71	50 / 230
heart	36%	603.01	313 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	21%	3.66	17 / 80
brain	0%	3.43	7 / 2642	7%	1.12	46 / 705
muscle	1%	18.82	12 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0008285	Biological process	negative regulation of cell population proliferation
GO_0030054	Cellular component	cell junction
GO_0032991	Cellular component	protein-containing complex
GO_0005829	Cellular component	cytosol
GO_0005886	Cellular component	plasma membrane
GO_0005925	Cellular component	focal adhesion
GO_0005634	Cellular component	nucleus
GO_0045296	Molecular function	cadherin binding
GO_0005515	Molecular function	protein binding
GO_0008270	Molecular function	zinc ion binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	TES
Protein name	Testin Testin variant Testin (TESS) Testin LIM domain protein
Synonyms	tcag7.1 hCG_39086
Description	FUNCTION: Scaffold protein that may play a role in cell adhesion, cell spreading and in the reorganization of the actin cytoskeleton. Plays a role in the regulation of cell proliferation. May act as a tumor suppressor. Inhibits tumor cell growth. .
Accessions	H7BYK1 ENST00000393484.2 A4D0U5 F8W7T0 ENST00000393481.6 [Q9UGI8-2] ENST00000492891.5 ENST00000455989.1 ENST00000358204.9 [Q9UGI8-1] Q9UGI8 E0X098 F8WDI4

TES report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review